您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策
您当前的位置:首页>>研究报告>>生物技术

2016-2021年全球血浆疗法市场研究报告
Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User, Region - Global Forecast to 2021

2016-2021年全球血浆疗法市场研究报告
【报告编号】:No.25871
【发布时间】:2016-07
【关 键 字】:plasma therapy     血浆疗法        
【报告页数】:212页
【报告价格】:电子版:5650美元
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 生物技术行业的相关报告
Report Description
 
The plasma therapy market is expected to grow from USD 135.6 million in 2016 to USD 297.6 million by 2021, at a CAGR of 14.0% from 2016 to 2021. This market is segmented on the basis of type, source, application, end user, and region. The pure PRP segment of the plasma therapy type market is expected to grow at the highest CAGR during the forecast period. Growth in this segment is mainly attributed to the high success rate of pure PRP therapy, less recovery time, and increase in healthcare expenditure worldwide.
 
Based on source, the plasma therapy market is segmented into autologous and allogenic. The autologous source segment is estimated to account for the largest share of the plasma therapy market in 2016. Prevalence of orthopedic disorders and the need for development of new therapies will drive the growth of this segment.
 
Based on application, the plasma therapy market is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery.  The dermatology application segment is expected to grow at the highest CAGR from 2016 to 2021, owing to increase in the number of cosmetic procedures and prevalence of dermatological disorders such as androgenic alopecia.
 
Based on end user, the plasma therapy market is segmented into hospitals & clinics and research institutes. The
hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy market in 2016.
Rise in healthcare spending has resulted in the increasing use of PRP in hospitals & clinics. 
 
On the basis of region, the plasma therapy market is led by North America, followed by Europe, Asia-Pacific, and rest of the world. Major factors contributing to the growth of the plasma therapy market include high incidences of trauma, increase in healthcare expenditure, and access to medical insurance in the U.S. On the other hand, stringent regulatory policies and side-effects associated with PRP therapy are restraining the growth of this market. 
 
The report provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition to this, the report also offers an overview of company profiles that comprise product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The market research data, current market size, and forecast of the future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to maintain their competitive position in the plasma therapy market.
 
Major players operating in the plasma therapy market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio Products Laboratory Ltd. (BPL) (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland).
 
Reasons to Buy the Report: 
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
 
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios of top players in the plasma therapy market.
 
The report analyzes the plasma therapy market on the basis of type, source, application, end user, and region.
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the plasma therapy market. 
• Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the plasma therapy market.
• Market Development: Comprehensive information about emerging markets; this report analyzes the market for various plasma therapy products across varied geographies. 
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma therapy market.
 
Table of Contents
 
1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21
 
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 KEY DATA FROM SECONDARY SOURCES 23
2.1.2 KEY DATA FROM PRIMARY SOURCES 24
2.1.2.1 Breakdown of primary interview 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 RESEARCH ASSUMPTIONS 27
 
3 EXECUTIVE SUMMARY 28
 
4 PREMIUM INSIGHTS 32
4.1 ATTRACTIVE OPPORTUNITIES IN THE GLOBAL PLASMA THERAPY MARKET 32
4.2 CURRENT TRENDS IN THE PLASMA THERAPY MARKET 35
 
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.2.1 PLASMA THERAPY MARKET, BY TYPE 37
5.2.2 PLASMA THERAPY MARKET, BY SOURCE 37
5.2.3 PLASMA THERAPY MARKET, BY APPLICATION 38
5.2.4 PLASMA THERAPY MARKET, BY END USER 38
5.3 MARKET DYNAMICS 39
5.3.1 MARKET DRIVERS 40
5.3.1.1 Rising incidences of sports injuries 40
5.3.1.2 Increase in the number of androgenic alopecia patients worldwide 41
5.3.1.3 Growing use of platelet-rich plasma in various therapeutic areas 41
5.3.1.4 Prevalence of arthritis 41
5.3.2 MARKET RESTRAINTS 42
5.3.2.1 Lack of reimbursement policies 42
5.3.2.2 Varying prices of plasma therapy 42
5.3.3 MARKET OPPORTUNITIES 43
5.3.3.1 Increase in the number of patients suffering from orthopedic disorders and androgenic alopecia 43
5.3.4 MARKET CHALLENGES 43
5.3.4.1 Restricted use of PRP in patients suffering from diabetes and kidney ailments 43
5.3.4.2 Developments in other fields of regenerative medicine 44
 
6 PLASMA THERAPY MARKET, BY TYPE 45
6.1 INTRODUCTION 46
6.2 PURE PRP 47
6.3 LEUKOCYTE-RICH PRP 49
6.4 PURE PLATELET-RICH FIBRIN 50
6.5 LEUKOCYTE-RICH FIBRIN 52
 
7 PLASMA THERAPY MARKET, BY SOURCE 53
7.1 INTRODUCTION 54
7.1.1 AUTOLOGOUS 55
7.1.2 ALLOGENIC 56
 
8 PLASMA THERAPY MARKET, BY APPLICATION 58
8.1 INTRODUCTION 59
8.2 ORTHOPEDIC 60
8.2.1 ARTHRITIS 63
8.2.2 CHRONIC TENDINITIS 63
8.2.3 BONE REPAIR & REGENERATION 64
8.3 DERMATOLOGY 65
8.3.1 ANDROGENIC ALOPECIA 66
8.3.2 PLASTIC SURGERY 68
8.4 CARDIAC MUSCLE INJURY 69
8.5 DENTAL 70
8.6 NERVE INJURY 72
8.7 OTHERS 73
 
9 PLASMA THERAPY MARKET, BY END USER 74
9.1 INTRODUCTION 75
9.2 HOSPITALS & CLINICS 76
9.3 RESEARCH INSTITUTES 78
10 PLASMA THERAPY MARKET, BY GEOGRAPHY 80
10.1 INTRODUCTION 81
10.2 NORTH AMERICA 82
10.2.1 COMPETITION IN NORTH AMERICA PLASMA THERAPY MARKET 84
10.2.2 NEAR-TERM, MID-TERM, AND LONG-TERM GROWTH OF THE PLASMA THERAPY MARKET IN U.S. AND CANADA 84
10.2.3 NORTH AMERICA PLASMA THERAPY MARKET, BY TYPE 85
10.2.4 NORTH AMERICA PLASMA THERAPY MARKET, BY SOURCE 86
10.2.5 NORTH AMERICA PLASMA THERAPY MARKET, BY APPLICATION 87
10.2.6 NORTH AMERICA PLASMA THERAPY MARKET, BY END USER 90
10.2.7 U.S. 92
10.2.7.1 U.S. PLASMA THERAPY MARKET OVERVIEW 92
10.2.7.2 U.S. PLASMA THERAPY MARKET, BY TYPE 93
10.2.7.3 U.S. PLASMA THERAPY MARKET, BY SOURCE 93
10.2.7.4 U.S. PLASMA THERAPY MARKET, BY APPLICATION 94
10.2.7.5 U.S. PLASMA THERAPY MARKET, BY END USER 95
10.2.8 CANADA 95
10.2.8.1 CANADA PLASMA THERAPY MARKET OVERVIEW 96
10.2.8.2 CANADA PLASMA THERAPY MARKET, BY TYPE 96
10.2.8.3 CANADA PLASMA THERAPY MARKET, BY SOURCE 97
10.2.8.4 CANADA PLASMA THERAPY MARKET, BY APPLICATION 97
10.2.8.5 CANADA PLASMA THERAPY MARKET, BY END USER 99
10.3 EUROPE 100
10.3.1 INTRODUCTION 100
10.3.1.1 COMPETITION IN THE EUROPE PLASMA THERAPY MARKET 102
10.3.1.2 NEAR-TERM, MID-TERM, AND LONG-TERM GROWTH OF THE PLASMA THERAPY MARKET IN EUROPE 103
10.3.1.3 EUROPE PLASMA THERAPY MARKET, BY TYPE 103
10.3.1.4 EUROPE PLASMA THERAPY MARKET, BY SOURCE 104
10.3.1.5 EUROPE PLASMA THERAPY MARKET, BY APPLICATION 105
10.3.1.6 EUROPE PLASMA THERAPY MARKET, BY END USER 108
10.3.1.7 EUROPE PLASMA THERAPY MARKET, BY COUNTRY 109
10.3.2 GERMANY 110
10.3.2.1 GERMANY PLASMA THERAPY MARKET OVERVIEW 110
10.3.2.2 GERMANY PLASMA THERAPY MARKET, BY TYPE 111
10.3.2.3 GERMANY PLASMA THERAPY MARKET, BY SOURCE 111
10.3.2.4 GERMANY PLASMA THERAPY MARKET, BY APPLICATION 112
10.3.2.5 GERMANY PLASMA THERAPY MARKET, BY END USER 113
10.3.3 U.K. 114
10.3.3.1 U.K. PLASMA THERAPY MARKET OVERVIEW 114
10.3.3.2 U.K. PLASMA THERAPY MARKET, BY TYPE 114
10.3.3.3 U.K. PLASMA THERAPY MARKET, BY SOURCE 115
10.3.3.4 U.K. PLASMA THERAPY MARKET, BY APPLICATION 115
10.3.3.5 U.K. PLASMA THERAPY MARKET, BY END USER 116
10.3.4 FRANCE 117
10.3.4.1 FRANCE PLASMA THERAPY MARKET OVERVIEW 117
10.3.4.2 FRANCE PLASMA THERAPY MARKET, BY TYPE 117
10.3.4.3 FRANCE PLASMA THERAPY MARKET, BY SOURCE 118
10.3.4.4 FRANCE PLASMA THERAPY MARKET, BY APPLICATION 118
10.3.4.5 FRANCE PLASMA THERAPY MARKET, BY END USER 119
10.3.5 SPAIN 120
10.3.5.1 SPAIN PLASMA THERAPY MARKET OVERVIEW 120
10.3.5.2 SPAIN PLASMA THERAPY MARKET, BY TYPE 120
10.3.5.3 SPAIN PLASMA THERAPY MARKET, BY SOURCE 121
10.3.5.4 SPAIN PLASMA THERAPY MARKET, BY APPLICATION 121
10.3.5.5 SPAIN PLASMA THERAPY MARKET, BY END USER 122
10.3.6 ITALY 123
10.3.6.1 ITALY PLASMA THERAPY MARKET OVERVIEW 123
10.3.6.2 ITALY PLASMA THERAPY MARKET, BY TYPE 123
10.3.6.3 ITALY PLASMA THERAPY MARKET, BY SOURCE 124
10.3.6.4 ITALY PLASMA THERAPY MARKET, BY APPLICATION 124
10.3.6.5 ITALY PLASMA THERAPY MARKET, BY END USER 125
10.3.7 REST OF EUROPE (ROE) 126
10.3.7.1 REST OF EUROPE PLASMA THERAPY MARKET OVERVIEW 126
10.3.7.2 REST OF EUROPE PLASMA THERAPY MARKET, BY TYPE 126
10.3.7.3 REST OF EUROPE PLASMA THERAPY MARKET, BY SOURCE 127
10.3.7.4 REST OF EUROPE PLASMA THERAPY MARKET, BY APPLICATION 127
10.3.7.5 REST OF EUROPE PLASMA THERAPY MARKET, BY END USER 129
10.4 ASIA-PACIFIC 130
10.4.1 INTRODUCTION 130
10.4.1.1 COMPETITION IN ASIA-PACIFIC PLASMA THERAPY MARKET 131
10.4.1.2 NEAR TERM, MID TERM, AND LONG TERM GROWTH OF PLASMA THERAPY MARKET IN APAC 132
10.4.2 ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE 132
10.4.3 ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE 133
10.4.4 ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION 134
10.4.5 ASIA-PACIFIC PLASMA THERAPY MARKET, BY END USER 137
10.4.6 ASIA-PACIFIC PLASMA THERAPY MARKET, BY COUNTRY 138
10.4.7 JAPAN 139
10.4.7.1 OVERVIEW 139
10.4.7.2 JAPAN PLASMA THERAPY MARKET, BY TYPE 140
10.4.7.3 JAPAN PLASMA THERAPY MARKET, BY SOURCE 140
10.4.7.4 JAPAN PLASMA THERAPY MARKET, BY APPLICATION 141
10.4.7.5 JAPAN PLASMA THERAPY MARKET, BY END USER 142
10.4.8 CHINA 143
10.4.8.1 OVERVIEW 143
10.4.8.2 CHINA PLASMA THERAPY MARKET, BY TYPE 143
10.4.8.3 CHINA PLASMA THERAPY MARKET, BY SOURCE 143
10.4.8.4 CHINA PLASMA THERAPY MARKET, BY APPLICATION 144
10.4.8.5 CHINA PLASMA THERAPY MARKET, BY END USER 145
10.4.9 AUSTRALIA 146
10.4.9.1 OVERVIEW 146
10.4.9.2 AUSTRALIA PLASMA THERAPY MARKET, BY TYPE 146
10.4.9.3 AUSTRALIA PLASMA THERAPY MARKET, BY SOURCE 147
10.4.9.4 AUSTRALIA PLASMA THERAPY MARKET, BY APPLICATION 147
10.4.9.5 AUSTRALIA PLASMA THERAPY MARKET, BY END USER 148
10.4.10 INDIA 149
10.4.10.1 OVERVIEW 149
10.4.10.2 INDIA PLASMA THERAPY MARKET, BY TYPE 149
10.4.10.3 INDIA PLASMA THERAPY MARKET, BY SOURCE 150
10.4.10.4 INDIA PLASMA THERAPY MARKET, BY APPLICATION 150
10.4.10.5 INDIA PLASMA THERAPY MARKET, BY END USER 151
10.4.11 REPUBLIC OF KOREA 152
10.4.11.1 OVERVIEW 152
10.4.11.2 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY TYPE 152
10.4.11.3 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY SOURCE 153
10.4.11.4 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY APPLICATION 153
10.4.11.5 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY END USER 155
10.4.12 REST OF ASIA-PACIFIC 155
10.4.12.1 OVERVIEW 155
10.4.12.2 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE 156
10.4.12.3 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE 156
10.4.12.4 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET,  BY APPLICATION 157
10.4.12.5 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY END USER 158
10.5 REST OF THE WORLD (ROW) 159
10.5.1 ROW PLASMA THERAPY MARKET, BY TYPE 160
10.5.2 ROW PLASMA THERAPY MARKET, BY SOURCE 161
10.5.3 ROW PLASMA THERAPY MARKET, BY APPLICATION 162
10.5.4 ROW PLASMA THERAPY MARKET, BY END USER 165
 
11 COMPETITIVE LANDSCAPE 166
11.1 OVERVIEW 166
11.2 MARKET SHARE ANALYSIS 167
11.3 COMPETITIVE SITUATION AND TRENDS 167
11.3.1 REGULATORY APPROVALS 168
11.3.2 EXPANSIONS 170
11.3.3 AGREEMENTS 172
11.3.4 NEW PRODUCT LAUNCHES 173
11.3.5 ACQUISITIONS 173
 
12 COMPANY PROFILE 174
(Overview, Financial*, Products & Services, Strategy, and Developments)
12.1 BIOLIFE PLASMA SERVICES 174
12.2 CAMBRYN BIOLOGICS LLC 177
12.3 BIOTEST 179
12.4 CSL LTD. 183
12.5 GRIFOLS INTERNATIONAL S.A. 186
12.6 KEDRION S.P.A. 189
12.7 LFB SA 192
12.8 BIO PRODUCT LABORATORY LTD. (BPL) 195
12.9 CHINA BIOLOGIC PRODUCTS, INC. 196
12.10 OCTAPHARMA 199
*Details might not be captured in case of unlisted companies.
 
13 APPENDIX 202
13.1 INSIGHTS FROM INDUSTRY EXPERTS 202
13.2 DISCUSSION GUIDE 203
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 207
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 208
13.5 AVAILABLE CUSTOMIZATIONS 210
13.6 RELATED REPORTS 210
 
List Of Tables
TABLE 1 INDICATIONS FOR THERAPEUTIC USE OF PLASMA - FIRST LINE THERAPY 33
TABLE 2 INDICATIONS FOR THERAPEUTIC USE OF PLASMA - SECOND LINE THERAPY 34
TABLE 3 PLASMA THERAPY MARKET BY TYPE, 2014–2021 (USD MILLION) 47
TABLE 4 PURE PRP MARKET, BY REGION, 2014–2021 (USD MILLION) 48
TABLE 5 LEUKOCYTE-RICH PRP MARKET, BY REGION, 2014–2021 (USD MILLION) 50
TABLE 6 PURE PLATELET-RICH FIBRIN MARKET, BY REGION, 2014–2021 (USD MILLION) 51
TABLE 7 LEUKOCYTE-RICH FIBRIN MARKET, BY REGION, 2014–2021 (USD MILLION) 52
TABLE 8 PLASMA THERAPY MARKET , BY SOURCE, 2014–2021 (USD MILLION) 55
TABLE 9 AUTOLOGOUS SOURCE MARKET , BY REGION, 2014–2021 (USD MILLION) 56
TABLE 10 ALLOGENIC SOURCE MARKET , BY REGION, 2014–2021 (USD MILLION) 57
TABLE 11 PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 60
TABLE 12 PLASMA THERAPY MARKET FOR ORTHOPEDIC, BY APPLICATION,  
2014–2021 (USD MILLION) 61
TABLE 13 PLASMA THERAPY MARKET FOR ORTHOPEDIC APPLICATION, BY REGION,  
2014–2021 (USD MILLION) 62
TABLE 14 PLASMA THERAPY MARKET FOR ARTHRITIS APPLICATION, BY REGION,  
2014–2021 (USD MILLION) 63
TABLE 15 PLASMA THERA[Y MARKET FOR CHRONIC TENDINITIS APPLICATION, 
BY REGION,  2014–2021 (USD MILLION) 64
TABLE 16 PLASMA THERAPY MARKET FOR BONE REPAIR & REGENERATION APPLICATION,  BY REGION, 2014–2021 (USD MILLION) 64
TABLE 17 PLASMA THERAPY MARKET FOR DERMATOLOGY APPLICATION, BY REGION,  
2014–2021 (USD MILLION) 66
TABLE 18 PLASMA THERAPY MARKET FOR ANDROGENIC ALOPECIA APPLICATION,  BY REGION, 2014–2021 (USD MILLION) 67
TABLE 19 PLASMA THERAPY MARKET FOR PLASTIC SURGERY APPLICATION,  BY REGION, 2014–2021 (USD MILLION) 68
TABLE 20 PLASMA THERAPY MARKET FOR CARDIAC MUSCLE INJURY APPLICATION, 
BY REGION, 2014–2021 (USD MILLION) 70
TABLE 21 PLASMA THERAPY MARKET FOR DENTAL APPLICATION, BY REGION, 
2014–2021 (USD MILLION) 71
TABLE 22 PLASMA THERAPY MARKET FOR NERVE INJURY APPLICATION, BY REGION,  
2014–2021 (USD MILLION) 72
TABLE 23 PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 76
TABLE 24 PLASMA THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION,  
2014–2021 (USD MILLION) 77
TABLE 25 PLASMA THERAPY MARKET FOR RESEARCH INSTITUTES, BY REGION,  
2014–2021 (USD MILLION) 79
TABLE 26 NORTH AMERICA PLASMA THERAPY MARKET, BY TYPE, 
2014–2021 (USD MILLION) 85
TABLE 27 NORTH AMERICA PLASMA THERAPY MARKET, BY SOURCE, 
2014–2021 (USD MILLION) 86
TABLE 28 NORTH AMERICA PLASMA THERAPY MARKET, BY APPLICATION,  
2014–2021 (USD MILLION) 87
TABLE 29 NORTH AMERICA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 88
TABLE 30 NORTH AMERICA PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 89
TABLE 31 NORTH AMERICA PLASMA THERAPY MARKET, BY END USER, 
2014–2021 (USD MILLION) 90
TABLE 32 NORTH AMERICA PLASMA THERAPY MARKET, BY COUNTRY, 
2014–2021 (USD MILLION) 91
TABLE 33 U.S. PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 93
TABLE 34 U.S. PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 93
TABLE 35 U.S. PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 94
TABLE 36 U.S. PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014–2021 (USD MILLION) 94
TABLE 37 U.S. PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE, 
2014–2021 (USD MILLION) 95
TABLE 38 U.S. PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 95
TABLE 39 CANADA PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 96
TABLE 40 CANADA PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 97
TABLE 41 CANADA PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 97
TABLE 42 CANADA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 98
TABLE 43 CANADA PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE, 
2014–2021 (USD MILLION) 98
TABLE 44 CANADA PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 99
TABLE 45 EUROPE PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 104
TABLE 46 EUROPE PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 105
TABLE 47 EUROPE PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 106
TABLE 48 EUROPE PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 107
TABLE 49 EUROPE PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 108
TABLE 50 EUROPE PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 109
TABLE 51 EUROPE PLASMA THERAPY MARKET, BY COUNTRY, 2014–2021 (USD MILLION) 110
TABLE 52 GERMANY PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 111
TABLE 53 GERMANY PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 111
TABLE 54 GERMANY PLASMA THERAPY MARKET, BY APPLICATION, 
2014–2021 (USD MILLION) 112
TABLE 55 GERMANY PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 112
TABLE 56 GERMANY PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 113
TABLE 57 GERMANY PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 113
TABLE 58 U.K. PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 114
TABLE 59 U.K. PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 115
TABLE 60 U.K. PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 115
TABLE 61 U.K. PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014–2021 (USD MILLION) 116
TABLE 62 U.K. PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE, 
2014–2021 (USD MILLION) 116
TABLE 63 U.K. PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 116
TABLE 64 FRANCE PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 117
TABLE 65 FRANCE PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 118
TABLE 66 FRANCE PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 118
TABLE 67 FRANCE PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 119
TABLE 68 FRANCE PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 119
TABLE 69 FRANCE PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 119
TABLE 70 SPAIN PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 120
TABLE 71 SPAIN PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 121
TABLE 72 SPAIN PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 121
TABLE 73 SPAIN PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014–2021 (USD MILLION) 122
TABLE 74 SPAIN PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 122
TABLE 75 SPAIN PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 122
TABLE 76 ITALY PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 123
TABLE 77 ITALY PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 124
TABLE 78 ITALY PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 124
TABLE 79 ITALY PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014–2021 (USD MILLION) 125
TABLE 80 ITALY PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 125
TABLE 81 ITALY PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 125
TABLE 82 REST OF EUROPE PLASMA THERAPY MARKET, BY TYPE, 
2014–2021 (USD MILLION) 126
TABLE 83 REST OF EUROPE PLASMA THERAPY MARKET, BY SOURCE, 
2014–2021 (USD MILLION) 127
TABLE 84 REST OF EUROPE PLASMA THERAPY MARKET, BY APPLICATION,  
2014–2021 (USD MILLION) 127
TABLE 85 REST OF EUROPE PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 128
TABLE 86 REST OF EUROPE PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 128
TABLE 87 REST OF EUROPE PLASMA THERAPY MARKET, BY END USER, 
2014–2021 (USD MILLION) 129
TABLE 88 ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2014-2021 (USD MILLION) 133
TABLE 89 ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE, 2014-2021 (USD MILLION) 134
TABLE 90 ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 
2014-2021 (USD MILLION) 135
TABLE 91 ASIA-PACIFIC PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014-2021 (USD MILLION) 136
TABLE 92 ASIA-PACIFIC PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014-2021 (USD MILLION) 137
TABLE 93 ASIA-PACIFIC PLASMA THERAPY MARKET, BY END USER, 
2014-2021 (USD MILLION) 138
TABLE 94 ASIA-PACIFIC PLASMA THERAPY MARKET, BY COUNTRY, 2014-2021 (USD MILLION) 139
TABLE 95 JAPAN PLASMA THERAPY MARKET, BY TYPE, 2014-2021 (USD MILLION) 140
TABLE 96 JAPAN: PLASMA THERAPY MARKET, BY SOURCE, 2014-2021 (USD MILLION) 140
TABLE 97 JAPAN PLASMA THERAPY MARKET, BY APPLICATION, 2014-2021 (USD MILLION) 141
TABLE 98 JAPAN PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014-2021 (USD MILLION) 141
TABLE 99 JAPAN PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014-2021 (USD MILLION) 142
TABLE 100 JAPAN PLASMA THERAPY MARKET, BY END USER, 2014-2021 (USD MILLION) 142
TABLE 101 CHINA PLASMA THERAPY MARKET, BY TYPE, 2014-2021 (USD MILLION) 143
TABLE 102 CHINA PLASMA THERAPY MARKET, BY SOURCE, 2014-2021 (USD MILLION) 144
TABLE 103 CHINA PLASMA THERAPY MARKET, BY APPLICATION, 2014-2021 (USD MILLION) 144
TABLE 104 CHINA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014-2021 (USD MILLION) 145
TABLE 105 CHINA PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014-2021 (USD MILLION) 145
TABLE 106 CHINA PLASMA THERAPY MARKET, BY END USER, 2014-2021 (USD MILLION) 145
TABLE 107 AUSTRALIA PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 146
TABLE 108 AUSTRALIA PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 147
TABLE 109 AUSTRALIA PLASMA THERAPY MARKET, BY APPLICATION, 
2014–2021 (USD MILLION) 147
TABLE 110 AUSTRALIA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2014–2021 (USD MILLION) 148
TABLE 111 AUSTRALIA PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 148
TABLE 112 AUSTRALIA PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 148
TABLE 113 INDIA PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 149
TABLE 114 INDIA PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 150
TABLE 115 INDIA PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 150
TABLE 116 INDIA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014–2021 (USD MILLION) 151
TABLE 117 INDIA PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 151
TABLE 118 INDIA PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 151
TABLE 119 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY TYPE, 
2014–2021 (USD MILLION) 152
TABLE 120 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY SOURCE,  
2014–2021 (USD MILLION) 153
TABLE 121 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY APPLICATION,  
2014–2021 (USD MILLION) 153
TABLE 122 REPUBLIC OF KOREA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  2014–2021 (USD MILLION) 154
TABLE 123 REPUBLIC OF KOREA PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE, 2014–2021 (USD MILLION) 154
TABLE 124 REPUBLIC OF KOREA PLASMA THERAPY MARKET, BY END USER,  
2014–2021 (USD MILLION) 155
TABLE 125 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 
2014–2021 (USD MILLION) 156
TABLE 126 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE,  
2014–2021 (USD MILLION) 156
TABLE 127 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION,  
2014–2021 (USD MILLION) 157
TABLE 128 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  2014–2021 (USD MILLION) 157
TABLE 129 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET IN DERMATOLOGY,  
2014–2021 (USD MILLION) 158
TABLE 130 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY END USER,  
2014–2021 (USD MILLION) 158
TABLE 131 ROW PLASMA THERAPY MARKET, BY TYPE, 2014–2021 (USD MILLION) 160
TABLE 132 ROW PLASMA THERAPY MARKET, BY SOURCE, 2014–2021 (USD MILLION) 161
TABLE 133 ROW PLASMA THERAPY MARKET, BY APPLICATION, 2014–2021 (USD MILLION) 162
TABLE 134 ROW PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2014–2021 (USD MILLION) 163
TABLE 135 ROW PLASMA THERAPY MARKET IN DERMARTOLOGY, BY TYPE,  
2014–2021 (USD MILLION) 164
TABLE 136 ROW PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 165
TABLE 137 REGULATORY APPROVALS, 2014–2016 168
TABLE 138 EXPANSIONS, 2013-2016 170
TABLE 139 AGREEMENTS, 2013-2016 172
TABLE 140 NEW PRODUCT LAUNCHES, 2013-2014 173
TABLE 141 ACQUISITIONS, 2013-2016 173
 
List Of Figures
FIGURE 1 GLOBAL PLASMA THERAPY MARKET 20
FIGURE 2 RESEARCH DESIGN 22
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, 
& REGION 24
FIGURE 4 BOTTOM-UP APPROACH 25
FIGURE 5 TOP-DOWN APPROACH 26
FIGURE 6 RESEARCH METHODOLOGY: DATA TRIANGULATION 27
FIGURE 7 LEUKOCYTE-RICH PRP PROJECTED TO BE THE FASTEST-GROWING SEGMENT IN THE PLASMA THERAPY MARKET 28
FIGURE 8 THE AUTOLOGOUS SEGMENT ESTIMATED TO DOMINATE THE PLASMA THERAPY MARKET IN 2016 29
FIGURE 9 DERMATOLOGY ESTIMATED TO BE THE FASTEST-GROWING APPLICATION OF THE PLASMA THERAPY MARKET 29
FIGURE 10 THE HOSPITALS & CLINICS SEGMENT ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE IN 2016 30
FIGURE 11 EUROPE ESTIMATED TO GROW AT THE HIGHEST CAGR IN THE PLASMA THERAPY MARKET 31
FIGURE 12 GLOBAL PLASMA THERAPY MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 32
FIGURE 13 THE PURE PRP SEGMENT ESTIMATED TO LEAD THE GLOBAL PLASMA THERAPY MARKET IN 2016 33
FIGURE 14 THE PLASMA THERAPY MARKET IN EUROPE TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 34
FIGURE 15 INCREASING USE OF PRP THERAPY IN SPORTS INJURIES TO PROPEL THE GROWTH OF THE PLASMA THERAPY MARKET 39
FIGURE 16 PLASMA THERAPY MARKET SEGMENTATION, BY TYPE 46
FIGURE 17 LEUKOCYTE-RICH PRP TO FORM THE LARGEST TYPE SEGMENT IN 2016 46
FIGURE 18 NORTH AMERICA TO DOMINATE THE PURE PRP MARKET IN 2016 48
FIGURE 19 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE LEUKOCYTE-RICH PRP MARKET IN 2016 49
FIGURE 20 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF PURE PLATELET-RICH FIBRIN MARKET IN 2016 51
FIGURE 21 NORTH AMERICA TO DOMINATE THE LEUKOCYTE-RICH FIBRIN MARKET IN 2016 52
FIGURE 22 PLASMA THERAPY MARKET SEGMENTATION, BY SOURCE 54
FIGURE 23 ALLOGENIC SOURCE TO BE THE LARGEST SEGMENT IN 2016 54
FIGURE 24 NORTH AMERICA TO LEAD THE AUTOLOGOUS SOURCE MARKET IN 2016 56
FIGURE 25 NORTH AMERICA TO LEAD THE ALLOGENIC SOURCE MARKET IN 2016 57
FIGURE 26 PLASMA THERAPY MARKET SEGMENTATION, BY APPLICATION 59
FIGURE 27 DERMATOLOGY SEGMENT TO DOMINATE THE PLASMA THERAPY APPLICATIONS MARKET IN 2016 59
FIGURE 28 ARTHRITIS TREATMENT TO DOMINATE THE PLASMA THERAPY MARKET FOR ORTHOPEDIC IN 2016 61
FIGURE 29 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PLASMA THERAPY MARKET FOR ORTHOPEDIC APPLICATION IN 2016 62
FIGURE 30 NORTH AMERICA TO DOMINATE THE PLASMA THERAPY MARKET FOR DERMATOLOGY APPLICATION IN 2016 66
FIGURE 31 ANDROGENIC ALOPECIA APPLICATION IN 2016 67
FIGURE 32 PLASTIC SURGERY IN 2016 68
FIGURE 33 NORTH AMERICA TO DOMINATE THE PLASMA THERAPY MARKET FOR CARDIAC MUSCLE INJURY APPLICATION IN 2016 69
FIGURE 34 NORTH AMERICA TO DOMINATE THE PLASMA THERAPY MARKET FOR DENTAL APPLICATION IN 2016 71
FIGURE 35 NORTH AMERICA TO DOMINATE THE PLASMA THERAPY MARKET FOR NERVE INJURY APPLICATION IN 2016 72
FIGURE 36 PLASMA THERAPY MARKET SEGMENTATION, BY END USER 75
FIGURE 37 PLASMA THERAPY MARKET SIZE, BY END USER, 2016 & 2021 (USD MILLION) 75
FIGURE 38 HOSPITALS & CLINICS OVERVIEW 76
FIGURE 39 NORTH AMERICA TO DOMINATE THE PLASMA THERAPY MARKET FOR HOSPITALS & CLINICS IN 2016 77
FIGURE 40 NORTH AMERICA TO DOMINATE THE PLASMA THERAPY MARKET FOR RESEARCH INSTITUTES BETWEEN 2016 AND 2021 78
FIGURE 41 GEOGRAPHIC SNAPSHOT (2016-2021) – THE MARKET IN THE U.K. EXPECTED TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 81
FIGURE 42 THE LEUKOCYTE-RICH PRP SEGMENT HAS HIGH GROWTH POTENTIAL ACROSS ALL REGIONS 82
FIGURE 43 NORTH AMERICA PLASMA THERAPY MARKET SNAPSHOT 83
FIGURE 44 NORTH AMERICA PLASMA THERAPY MARKET, BY TYPE, 2016 (USD MILLION) 85
FIGURE 45 NORTH AMERICA PLASMA THERAPY MARKET, BY SOURCE, 
2014-2021 (USD MILLION) 86
FIGURE 46 NORTH AMERICA PLASMA THERAPY MARKET, BY APPLICATION, 
2016 & 2021 (USD MILLION) 87
FIGURE 47 NORTH AMERICA PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2016 & 2021 (USD MILLION) 88
FIGURE 48 NORTH AMERICA PLASMA THERAPY MARKET IN  DERMATOLOGY, BY TYPE, 
2016 & 2021 (USD MILLION) 89
FIGURE 49 NORTH AMERICA PLASMA THERAPY MARKET, BY END-USER, 
2014-2021  (USD MILLION) 90
FIGURE 50 NORTH AMERICA PLASMA THERAPY MARKET, BY COUNTRY,  
2016 & 2021 (USD MILLION) 91
FIGURE 51 U.S. PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 92
FIGURE 52 CANADA PLASMA THERAPY MARKET OVERVIEW 96
FIGURE 53 EUROPE PLASMA THERAPY MARKET SNAPSHOT – GERMANY IS THE MOST LUCRATIVE MARKET 100
FIGURE 54 EUROPE PLASMA THERAPY MARKET, BY TYPE, 2016 (USD MILLION) 103
FIGURE 55 EUROPE PLASMA THERAPY MARKET, BY SOURCE, 2014-2021 (USD MILLION) 104
FIGURE 56 EUROPE PLASMA THERAPY MARKET, BY APPLICATION,  
2016 & 2021 (USD MILLION) 105
FIGURE 57 EUROPE PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE, 
2016 & 2021 (USD MILLION) 106
FIGURE 58 EUROPE PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE, 
2016 & 2021 (USD MILLION) 107
FIGURE 59 EUROPE PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 108
FIGURE 60 EUROPE PLASMA THERAPY MARKET, BY COUNTRY,  2016 & 2021 (USD MILLION) 109
FIGURE 61 GERMANY PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 110
FIGURE 62 U.K. PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 114
FIGURE 63 FRANCE PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 117
FIGURE 64 SPAIN PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 120
FIGURE 65 ITALY PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 123
FIGURE 66 REST OF EUROPE PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 126
FIGURE 67 APAC PLASMA THERAPY MARKET SNAPSHOT – CHINA IS THE MOST LUCRATIVE MARKET 130
FIGURE 68 APAC PLASMA THERAPY MARKET , BY TYPE, 2016 (USD MILLION) 132
FIGURE 69 APAC PLASMA THERAPY MARKET, BY SOURCE, 2014-2021 (USD MILLION) 133
FIGURE 70 APAC PLASMA THERAPY MARKET , BY APPLICATION, 2016 & 2021 (USD MILLION) 134
FIGURE 71 APAC PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2016 & 2021 (USD MILLION) 135
FIGURE 72 APAC PLASMA THERAPY MARKET IN  DERMATOLOGY, BY TYPE,  
2016 & 2021 (USD MILLION) 136
FIGURE 73 APAC PLASMA THERAPY MARKET , BY END USER, 2014-2021 (USD MILLION) 137
FIGURE 74 APAC PLASMA THERAPY MARKET , BY COUNTRY, 2016 & 2021 (USD MILLION) 138
FIGURE 75 JAPAN PLASMA THERAPY MARKET OVERVIEW,2016 & 2021 139
FIGURE 76 CHINA PLASMA THERAPY MARKET OVERVIEW,2016 & 2021 143
FIGURE 77 AUSTRALIA PLASMA THERAPY MARKET OVERVIEW,2016 & 2021 146
FIGURE 78 INDIA PLASMA THERAPY MARKET OVERVIEW,2016 & 2021 149
FIGURE 79 REPUBLIC OF KOREA PLASMA THERAPY MARKET OVERVIEW,2016 & 2021 152
FIGURE 80 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET OVERVIEW, 2016 & 2021 155
FIGURE 81 PURE PRP ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE IN THE ROW PLASMA THERAPY MARKET IN 2016 159
FIGURE 82 ROW PLASMA THERAPY MARKET OVERVIEW,2016 160
FIGURE 83 ROW PLASMA THERAPY MARKET ,BY SOURCE ,2014 TO 2021 (USD MILLION) 161
FIGURE 84 ROW PLASMA THERAPY MARKET ,BY APPLICATION , 2016 & 2021  (USD MILLION) 162
FIGURE 85 ROW PLASMA THERAPY MARKET IN ORTHOPEDIC, BY TYPE,  
2016–2021 (USD MILLION) 163
FIGURE 86 ROW PLASMA THERAPY MARKET IN DERMATOLOGY, BY TYPE,  
2016 & 2021 (USD MILLION) 164
FIGURE 87 ROW PLASMA THERAPY MARKET, BY END USER, 2014–2021 (USD MILLION) 165
FIGURE 88 LEADING MARKET PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES IN THE PAST FOUR YEARS (2013–2016) 166
FIGURE 89 GLOBAL PLASMA THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 167
FIGURE 90 BATTLE FOR MARKET SHARE: ACQUISITIONS, EXPANSIONS, AND PARTNERSHIPS ARE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS 167
FIGURE 91 BAXALTA INC: COMPANY SNAPSHOT 174
FIGURE 92 BIOTEST: COMPANY SNAPSHOT 179
FIGURE 93 CSL LTD.: COMPANY SNAPSHOT 183
FIGURE 94 GRIFOLS INTERNATIONAL S.A.: COMPANY SNAPSHOT 186
FIGURE 95 KEDRION S.P.A.: COMPANY SNAPSHOT 189
FIGURE 96 LFB SA: COMPANY SNAPSHOT 192
FIGURE 97 CHINA BIOLOGIC PRODUCTS, INC.: COMPANY SNAPSHOT 196
FIGURE 98 OCTAPHARMA: COMPANY SNAPSHOT 199
 

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统